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Background: To prescribe early trismus therapy, prognostic factors influenc-
ing the restricted mouth opening should be identified first. Our aim is to pre-
sent an overview of these factors in patients with head and neck cancer.
Methods: PubMed, Cochrane, EMBASE, and CINAHL were searched using
terms related to head and neck cancer and mouth opening. Risk of bias was
assessed using the “Quality in Prognosis Studies” tool. A best evidence synthe-
sis was performed.
Results: Of the identified 1418 studies, 53 were included. Three studies con-
tained a prognostic multivariate model for a restricted mouth opening.
Conclusions: Patients with head and neck cancer will most likely develop a
restricted mouth opening when they have a large tumor near the masticatory
muscles that requires extensive cancer treatment. A restricted mouth opening
most likely occurs within 6 months after cancer treatment. Further research is
necessary on factors related to healing tendency or pain intensity.
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1 | INTRODUCTION
Trismus, a restricted mouth opening, is considered to be
one of the three most burdensome side effects after head
and neck cancer treatment.1-3 Daily activities, such as
speaking, eating, and swallowing become more difficult.4-6
As a consequence, trismus impacts the quality of life.7,8
In order to prevent or to treat trismus, stretching regi-
mens are often prescribed to increase mouth opening.9 In
2016, a systematic review analyzed the effects of various
stretching regimens, but none of them was found to be
superior.10 It has been suggested that early initiation of a
therapy for trismus results in a greater improvement in
mouth opening.11 However, when the effectiveness of an
early, preventive stretching regimen was analyzed, no sig-
nificant difference between the exercise group and con-
trol group was found.12 Not all the patients may have
been at risk for trismus, which would have hindered the
detection of the effectiveness of the therapy. Moreover,
the group of patients not at risk of developing trismusRegistration: Prospero CRD42017071400.
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was unnecessarily burdened with an intensive stretching
regimen.
Thus, factors influencing trismus should be identified
so that only the patients at risk for trismus are subjected
to therapy. Previous studies examined the factors associ-
ated with trismus but the criteria they applied varied (eg,
a maximal mouth opening [MMO] of less than 20 mm13
or less than 35 mm14). They used different assessment
methods (eg, objective measurement using a millimeter
scale15,16 or perceived difficulties opening the mouth
using questionnaires17,18), or different study populations
(eg, patients receiving radiotherapy15,19 or
chemoradiotherapy19,20). There is no recent systematic
review available on prognostic factors for trismus in
patients with head and neck cancer in general.
The aim of this systematic review is to identify the
prognostic factors for trismus (measured objectively and
subjectively) in patients treated for head and neck cancer.
2 | MATERIALS AND METHODS
The protocol for this systematic review is registered in Pros-
pero (Register code: CRD42017071400). The study will be
reported according to the Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses (PRISMA) statement.
2.1 | Literature search
Four databases were searched for eligible studies:
PubMed, Cochrane, Excerpta medica dataBASE
(EMBASE), and Cumulative index to nursing and allied
health literature (CINAHL). The search strategy was
developed in cooperation with an information specialist
and included MesH terms and free text regarding head
and neck cancer and mouth opening (Supplementary
Information S1). All the databases were searched in
November 2017. An update was performed in July 2019.
2.2 | Eligibility criteria
Prospective longitudinal studies were included if at least
two measurement moments, regarding objective mea-
surements of trismus (trismus and MMO) or subjective
assessments of trismus (perceived difficulties with open-
ing the mouth), were reported. No distinction was made
between active or passive mouth opening measurements.
Studies of trismus therapies were excluded, unless they
reported data on a restricted mouth opening of a control
group that did not receive a form of trismus therapy. (Sys-
tematic) reviews, in vitro studies, comments, letters to
the editor, and case reports of less than 10 patients were
excluded. There were no language or time restrictions.
Studies written in languages that could not be understood
by the authors were translated. Additionally, a full-text
version had to be available in order to be included for fur-
ther assessment and data extraction.
2.3 | Study selection
After removing any duplicates, the titles and abstracts
were assessed for inclusion independently by J.G., P.R.,
and P.D. The assessors J.G. and P.D. independently
assessed the full text versions for inclusion. Any disagree-
ments between them were resolved by discussion. In case
no consensus could be reached, a third observer (K.D.)
was consulted. Interobserver reliability was measured
through Cohen's kappa and percentage of agreement.
Google Scholar, the references of the relevant system-
atic reviews and the references of the eligible studies
were checked by J.G. for studies missed in the database
search. When a study was considered eligible, the full text
paper was screened and assessed by J.G. and P.D. inde-
pendently, according to the original protocol.
The studies that only reported descriptive data and
did not perform any statistical tests to analyze the influ-
ence of factors on trismus, MMO, or perceived difficulties
opening the mouth, were excluded.
2.4 | Data extraction
One reviewer (J.G.) extracted all required information
from the studies, which included sample size, patient
characteristics (age, sex), tumor characteristics (tumor
localization, T classification, N classification, tumor
stage, histology), treatment characteristics (treatment
modality), and method of outcome measurements
(number of measurement points reported, follow-up
time). Percentage of patients with trismus (based on a
cut-off point), difference in means or medians of MMO
between two measurements (one measurement after
treatment minus measurement before treatment) were
recorded. In case of multivariate prognostic models, the
estimated effects and 95% confidence intervals were
extracted. Data of the univariate analysis or multivariate
analysis were extracted in case trismus, mouth opening,
difficulties opening the mouth, were analyzed over time.
A second reviewer (P.D.) extracted data from a ran-
dom sample of eight studies containing only univariate
analyses and the three studies containing multivariate
analyses. In case any data were missing or needed clarify-
ing, the corresponding authors were contacted by e-mail.
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2.5 | Risk of bias assessment
Included studies were assessed by J.G. and P.D. on risk of
bias using the “Quality In Prognosis Studies” tool
(QUIPS).21 This tool is designed to assess the risk of bias
in prognostic studies. The tool assesses the following
items: study participation, study attrition, prognostic factor
measurement, outcome measurement, study confounding,
and statistical analysis and reporting. The risk of bias can
be scored low, moderate, or high. We added the option
“not applicable” which could be chosen in case the studies
did not provide adequate information to be able to assess
that specific domain. As attrition is commonly high in
studies including patients with head and neck cancer due
to early decease, we predefined the following criteria:
when the study attrition is more than 20%, but no specifi-
cations are given, we assessed the study as high risk of bias
on the study attrition domain. When the study attrition is
more than 20%, but specifications are given, we assessed
the study as moderate risk of bias on the study attrition
domain. For the statistical analysis and reporting domain,
we scored a high risk of bias if the effect of only one factor
on restricted mouth opening was analyzed. J.G. and P.D.
were authors of two studies. These studies were assessed
by two independent assessors, K.D. and B.G., to reduce
the risk of assessor bias.
To assess the overall risk of bias of a study, it was
recommended to score the overall risk of bias as “low”
if at least all, or the most important domains (deter-
mined a priori), were rated as having a low risk of
bias.21 On that basis, we determined the overall risk of
bias to be low, if at least five out of six domains were
scored with a low risk of bias and the domains “study
confounding” and “statistical analysis and reporting”
were scored with a low risk of bias. These two domains
are of major importance for analyzing the influence of
factors on trismus, MMO or perceived difficulties open-
ing the mouth.
In case of disagreement between the reviewers, a con-
sensus meeting was held. If no consensus could be
reached, a third reviewer (K.D.) gave a binding verdict.
2.6 | Best evidence synthesis
Due to clinical and methodological heterogeneity between
the included studies, we did not perform a meta-analysis.
Instead, we performed a best evidence synthesis. Three
main domains were taken into account in order to rate the
level of evidence: quality, quantity, and consistency.22,23
We determined the evidence to be strong if two or more
studies (quantity) with an overall low risk of bias (quality)
and relatively consistent findings (consistency) of the
analyzed factors across the studies was found. Evidence
was determined to be moderate when evidence was pro-
vided including one study with an overall low risk of bias
and relatively consistent findings of the analyzed factors
across the studies. Evidence was determined to be limited
when evidence was provided by studies with an overall
high risk of bias and relatively consistent findings of the
analyzed factors across the studies. Evidence was deter-
mined to be limited/moderate when evidence was pro-
vided by a study with an overall high risk of bias, but in
which a multivariate prognostic model was presented. The
evidence was determined to be conflicting in case there
were inconsistencies between the findings of the analyzed
factors found across the studies.
3 | RESULTS
3.1 | Study selection
The first search resulted in 1703 hits. After duplicate
removal, 1199 papers were included for title and abstract
assessment (Cohen's kappa: 0.533, agreement 90%).
Although 141 were deemed suitable for full text assess-
ment after a consensus meeting (Cohen's kappa: 0.577,
agreement 81%), 40 papers were excluded: 37 were
abstracts only (eg, conference abstract or poster abstract),
one was a review, one was a comment in a forum, and
one full-text could not be retrieved. The corresponding
author was requested to provide the full text article, but
no response was received. A further 59 of the available
full text papers were excluded because they did not fulfill
the inclusion criteria.
The additional check in Google Scholar and the refer-
ences of the relevant studies and (systematic) reviews,
resulted in 16 other papers.5,17,24-37 After reading the full
text, two did not meet the inclusion criteria.20,24 A total
of 56 studies were included for risk of bias assessment
and data extraction. During the data extraction process,
an additional seven studies were excluded, because no
statistical analysis was performed to identify any factors
influencing trismus (n = 4)27,38-40 or because exercises to
increase mouth opening had been undertaken
(n = 2),26,41 or because only one measurement moment
was reported (n = 1)42 (Figure 1).
After an update of the search and the removal of
duplicates, 203 additional papers were identified. After
assessing the titles and abstracts (Cohen's kappa: 0.378,
agreement 80%), were included for assessment of the full
text (Cohen's kappa: 0.493, agreement 76%). Eventually,
four of those studies were included.43-46
The above procedures resulted in a final selection of
53 studies.5,13-20,28-37,43,45-77
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3.2 | Study characteristics
Sample sizes ranged from 14 to 641 patients (Table 1).
The number of measurement moments ranged from 2 to
20. The longest follow-up period was 5 years.
3.3 | Risk of bias assessment
The overall Cohen's kappa bias assessment score was
0.310 (52% agreement). The source or study population
was not described (adequately) in the majority of the
studies. These studies were scored with “N/A” on the
study participation domain (n = 32; 60%)
(Table 2).5,13,16,18,20,28,30,32,36,37,43,45-47,51-
58,60,61,64,65,68,69,72,73,75,77 Eleven studies (21%) did not
report attrition rate.13,19,33,35,51,55,61,70,72,73,77 Some did not
report the attrition rate because only the patients with
complete data were included. Four studies (8%) were
scored with “N/A" on the outcome measurement
domain14,16,55,60: two studies did not describe the mea-
surement method55,60 and two studies used a measure-
ment method that has not been validated (extra-oral
measurements).14,16 The majority of the studies were
scored with a high risk of bias concerning the statistical
analysis and reporting domain (n = 42; 79%) because
they lacked a multivariate analysis.5,13,14,17,18,20,28-37,43,45-
47,51,52,54-58,60-68,70,72-75,77
3.4 | Distinguishing the outcome
measurements
A distinction was made between objective (eg, using a
ruler or calliper) or subjective (eg, using a patient' ques-
tionnaire) assessments of restricted mouth opening. An
additional distinction was made between the objective
studies, namely using a restricted mouth opening as a
cut-off point (n = 6)13,14,47-50 or a decrease in MMO mea-
sured in millimeters (n = 16).15,16,43,51-63
The subjective analyses assessed the perception of a
restricted mouth opening either using the European Orga-
nization for Research and Treatment for Cancer Quality of
Life Questionnaire Head & Neck module- 35 (EORTC
QLQ H&N35) (n = 29)17,18,20,28-37,45,46,64-77 or an adden-
dum similar to the EORTC QLQ H&N35 (n = 1)5 or Com-
mon Terminology Criteria for Adverse Events (n = 1).19
The Gothenburg Trismus Questionnaire (n = 3) was used
as a secondary endpoint to assess trismus.48,49,63
3.5 | Univariate analyses
In 16 studies, a single prognostic factor for a decrease in
MMO and the patients' perception of difficulties with
opening the mouth was analyzed over time
(Table 3).14,16,35,43,46,53-58,62,65,71,72,74 Regarding patient
related factors, a significant effect was found in relation
to sex (in one study in the period between before and
after treatment)14 and the −509 genotype.56 Patients
with a homozygous T allele (TT) in the −509 genotype
had a greater reduction in MMO than those with a
homozygous C allele (CC) or heterozygous C allele (CT).
Tumor related factors included large reductions in
MMO when the tumor was located near the oral cavity
or oropharynx.53,54 Less reduction was found in other
areas, such as the nasopharynx, hypopharynx, larynx, or
lymph drainage areas.53,54 No significant effects were
found in relation to T classification or N classifica-
tion.14,16,65 Cancer treatment also resulted in a reduction
in MMO, with the most occurring after
chemoradiotherapy and the least after surgery.14 The
MMO decreased directly after surgery but increased in
FIGURE 1 Flowchart. *: 40 studies were not available,
because 37 were abstracts only (eg, conference abstract or poster
abstract), one was a review, one was a comment in a forum, and
one full-text could not be retrieved
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Yan et al (2003)13 N/A N/A L L H H H
Scott et al (2011)14 H H L N/Aa L H H
Lee et al (2012)47 N/A H L L M H H
Pauli et al (2013)48 M L L L L M H
Pauli et al (2016)49 L M M L M M H
van der Geer et al
(2016)50




N/A N/A L L M H H
Wang et al (2005)52 N/A M L L H H H
Bragante et al (2012)54 N/A M L L M H H
Mucke et al (2012)55 N/A N/A L N/A H H H
Lyons et al (2013)56 N/A M L M L H H
Lazarus et al (2014)57 N/A M L L H H H
Safdar et al (2014)58 N/A L L L H H H
Wetzels et al (2014)16 N/A M L N/Aa L L H
Bragante et al (2015)53 N/A L L L L L L
Fong et al (2015)59 H M L L H M H
Kamstra et al (2015)15 L H L M M L H
Manaktala et al
(2015)60
N/A L L N/A H H H
Nayar et al (2016)61 N/A N/A L L H H H
Al-Saleh et al (2017)43 N/A H L M H H H
Lalla et al (2017)62 H H L M H H H
Thor et al (2017)63 M H L L H H H
Subjective
measurements
De Graeff et al
(1999)17
L M L L H H H
De Graeff et al
(2000)29
L M L L M H H
Epstein et al (2000)5 N/A H L L M H H
Bjordal et al (2001)28 N/A L L L H H H
Hammerlid et al
2001)18
N/A L L M L H H
Ohrn et al (2001)33 M N/A L L H H H
Wiltfang et al (2003)34 L M L L H H H
Fang et al (2004)30 N/A M L L H H H
Abendstein et al
(2005)64
N/A L L L M H H
Fang et al (2005)31 L L L L H H H
10 van der GEER ET AL.
the 6 months thereafter. When patients received
(chemo) radiotherapy, the MMO decreased directly after
the treatment, but did not increase in the 6 months
thereafter. The MMO decreased even more with an
increase in radiation dose.54
Patients who were given conventional three-dimen-
sional radiotherapy, instead of intensity modulated radio-
therapy, perceived more difficulties opening the
mouth.35,71 Also, patients who underwent chemotherapy
without the addition of extracorporeal radiofrequency
perceived more difficulties with opening the mouth com-
pared with those who received additional extracorporeal
radiofrequency.72 Regarding the remaining factors, a
greater reduction in MMO was found when mucositis
was present compared to when mucositis was not pre-
sent.53 MMO was not significantly reduced in relation to
alcohol consumption and smoking factors.16 Patients
with a lower social economic status perceived more diffi-
culties with opening the mouth than patients with a mid-
dle or high social economic status.46
3.6 | Timing
The highest percentage of patients developed trismus
directly after treatment and it continued to increase in
the 6 months thereafter (Figure 2A). The percentage of
patients with trismus seemed to stabilize 12 months after
treatment. MMO decreased directly after treatment and
in the 6 months thereafter (Figure 2B) and appeared to
stabilize 12 months after treatment. Patients' perception





















N/A M L L M H H
Urdaniz et al (2005)37 N/A L L L M H H
Borggreven et al
(2007)65
N/A L L L M H H
Oates et al (2007)20 N/A L L L H H H
Bozec et al (2008)66 L H L L L H H
Bozec et al (2009)67 L M L L L H H
Rizvi et al (2009)68 N/A L L M H H H
Vergeer et al (2009)35 M N/A L L H H H
Yoshimura et al
(2009)69
N/A M M L L M H
Chan et al (2012)36 N/A L L L H H H
Al-Mamgani et al
(2013)70
L N/A L L M H H
Rathod et al (2013)71 L H L L L L L
Zhao et al (2014)72 N/A N/A L L H H H
Arslan et al (2015)73 N/A N/A L L H H H
Kumar et al (2013)74 L L L L H H H
Landstrom et al
(2015)75
N/A L L L H H H
Rao et al (2016)19 H N/A L M L L H
Dzioba et al (2017)76 L H L L M M H
Gao et al (2018)77 N/A N/A L L H H H
Tribius et al (2018)46 N/A L N/A L H H H
Veluthattil et al
(2019)45
N/A M L L H H H
Abbreviations: H, high risk of bias; L, low risk of bias; M, moderate risk of bias; N/A, not applicable.
aExtra-oral measurement.
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(Figure 2C). The majority of the patients perceived diffi-
culties with opening the mouth directly after treatment,
but thereafter the perception varied considerably.
The figures were based on 29 studies. Other studies
were not included because: they did not report data on
restricted mouth opening at time points before and after
oncological treatment (n = 14)19,34-
36,43,46,49,51,55,56,59,61,72,74; the trismus scores were reported
as a cumulative incidence13; MMO was reported as a nor-
malized value52; a mean reduction58; or as a median
score14; or the scores of the questionnaires were not
transformed into symptom scores (n = 3)5,44,68 or were
reported as a median score.45,75 The data from studies
that included the same study population as another study
were not displayed either.50
3.7 | Multivariate analyses
Eight studies built multivariate models affecting trismus,
mouth opening perceived difficulties opening the
mouth.15,16,19,48-50,53,76 Three of these studies built and
reported prognostic models taking time into account
(Table 4).15,53,76 Two of these studies analyzed factors
affecting MMO,15,53 and one study analyzed the factors
affecting perceived difficulties with opening the mouth.76
Presence of mucositis, deterioration of overall function-
ing (according to the Karnofsky Performance Status
Scale), tumors located near the oral cavity, oropharynx
and nasopharynx, nasal cavity and maxillary sinus,
shorter time after radiotherapy, female sex, a small base-
line mouth opening, large tumor (T stage 4), higher age,
and a great target volume (radiotherapy) were signifi-
cantly associated with a decrease in MMO. A combina-
tion of oncological treatment modalities (surgery and
(chemo) radiotherapy) and shorter time after oncological
treatment) were associated with perceived difficulties
with opening the mouth.
3.8 | Best evidence synthesis
There is moderate evidence that the presence of mucositis
and a deterioration of overall functioning (according to
the Karnofsky Performance Status Scale) results in a
reduction of MMO (Table 5). There is limited to moderate
evidence that target volume, time after treatment, and
baseline mouth opening results in a reduction of MMO,
and that time after treatment results in higher scores of
perceived difficulties opening the mouth. There is con-
flicting evidence that the factors age localization, age, T
classification, reconstruction after surgery, different types
of treatment modalities, and sex affect MMO, and that the
different types of treatment modalities affect perceived dif-
ficulties opening the mouth as well.
Conflicting evidence was mainly the result of a differ-
ent categorization of a particular factor across the studies.
For instance, a significant association between factor
tumor localization and MMO was found, if tumor locali-
zation was categorized in the two categories: “oral cavity
and oropharynx” vs “nasopharynx, hypopharynx and lar-
ynx.”53 However, no significant association was found
between factor tumor localization and MMO, if tumor
localization was categorized in the two categories “oral
cavity” vs “oropharynx.”14
Significant associations were found between a reduc-
tion in MMO and the factors: T classification: if stage 4
was compared to other stages; treatment modalities, if
multiple treatment modalities were compared to a single
treatment modality or (chemo)radiotherapy was compared
to surgery more than 6 months after treatment; recon-
struction, if platysma flap was compared with a submental
flap. A significant association between higher scores on
perceived difficulties opening the mouth and the factor
treatment modality was found, if multiple treatment
modalities were compared to one single treatment modal-
ity or chemoradiotherapy was compared to radiotherapy
alone. The largest reductions on MMO were found for a
greater target volume (limited to moderate evidence) and
the presence of mucositis after radiotherapy (moderate evi-
dence) (Table 4, estimated effects). The greatest increases
for perceived difficulties opening the mouth were found
for a combination of treatment modalities given (con-
flicting evidence) and time after treatment (limited to
moderate evidence) (Table 4, estimated effects).
4 | DISCUSSION
4.1 | Key results
A restricted mouth opening is most likely in patients with
head and neck cancer who have a large tumor near the
masticatory muscles that requires extensive cancer treat-
ment. A restricted mouth opening is most likely to occur
in the first 6 months after cancer treatment.
4.2 | Quality of studies
Overall, the quality of the studies was poor. Most studies
had a high risk of bias. Two studies had a low risk of bias,
but these studies did not build a multivariate prognostic
model. Factors that were most likely to affect trismus,
MMO, or perceiving difficulties opening the mouth, were
identified and described. These studies had moderate,
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Nasal cavity and maxillary
sinus
1.26 −4.00;6.53
Unknown primary - N/A
Time after radiotherapy 4.00 3.38;4.63




Tumor stage: T4 −1.14 −2.16;−0.11
Age −0.05 −0.08;−0.01
Target volume on primary
tumor
−4.76 −9.36;−0.17
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limited, or conflicting levels of evidence. Levels of strong
evidence were not reached. Nonetheless, this systematic
review gives insight into the factors that should be taken
into account in future research on a restricted mouth
opening in patients with head and neck cancer.
4.3 | Prognostic factors
Moderate evidence was found for the influence of
mucositis after radiotherapy on a reduction in MMO.53
The effect of mucositis on mouth opening is probably
related to the associated healing tendency and the asso-
ciated pain, since it was noted that MMO decreased in
the presence of mucositis and increased when the
mucositis resolved.78 The effects of pain on MMO, ana-
lyzed in the form of pain medication or alcohol (which
may act as a pain killer as well) have also been
reported.16,47,48 The effects of factors related to the
healing tendency or pain intensity on a restricted
























Nasal cavity or maxillary
sinus × time
0.62 −0.57;1.82




Male sex × time 0.32 0.11;0.54
Baseline age centered at
60 years × time
−0.01 −0.02;0.00
Tumor stage T4 × time −0.27 −0.50;−0.05



























1 month after treatment 12.42 5.2;19.6
6 months after treatment 11.30 3.7;18.9
1 year after treatment 2.86 −5.3;11.0
aSignificantly contributing to the model.
bKarnofsky Performance Scale: an index used to classify functional impairment, using a scale of 0-100.
cThe European Organization for Research and Treatment of Cancer Quality of Life Questionnaire—Head and Neck cancer Module 35: a vali-
dated quality of life questionnaire, specifically for head and neck cancer related symptoms.
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(+, −, or ±) Level of evidence
Maximal mouth opening reduction
Disease stage [54;57;53] 26;29;56 111 − Moderate





[53] 56 56 + Moderate
Diet consistency [53] 56 56 − Moderate
Larger target volume [15] 641 641 + Limited/Moderate
Shorter time after treatment [15] 641 641 + Limited/Moderate
Smaller baseline mouth
opening
[15] 641 641 + Limited/Moderate
Localization [16;53;15] 143;56;641 840 + Conflicting
Oral cavity (predominantly
maxilla) and oropharynx vs
other localizationsb
54 26 26 ±
[14;57;53c] 64;29;56 149 −
Age [15] 641 641 + Conflictingb
[14] 64 64 −
T classification [15] 641 641 + Conflicting
T classification stage 4 vs other
stages.b
[14;16] 64;143 207 −
Reconstruction [58] 65 65 + Conflicting
Platysma flap vs submental
flapb
[14;16] 64;143 207 −
Treatment modalities [16;43] 143;16 159 + Conflictingb
Multiple treatment modalities
vs single treatment modality;
(Chemo) radiotherapy vs
surgery > 6months
[14;55] 64;96 160 ±
[54] 26 26 −
Sex [15] 641 641 + Conflicting
[14] 64 64 ±
[16;62] 143;372 515 −
Dental status [14;16] 64;143 207 − Limited
Alcohol [16] 143 143 − Limited
Smoking [16] 143 143 − Limited
N classification [14] 64 64 − Limited
−509 genotype [56] 62 62 ± Limited
Higher radiation dose [54] 26 26 + Limited
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The healing process might also influence the impact of
other factors (such as time after treatment and different
types of treatment modalities) on a restricted mouth open-
ing. If time passes, it is likely that the affected tissues will
heal. The MMO might become less restricted or even
increase over time.15 The healing process might also differ
per treatment modality. For instance, in one study, the dif-
ferences in MMO reduction between surgery and (chemo)
radiotherapy over time were displayed: patients who had
surgery had a decrease in MMO directly after treatment,
but the MMO increased in the 6 months thereafter,
whereas the patients who received (chemo) radiotherapy
had a decrease in MMO directly after treatment, but the
MMO did not increase in the 6 months thereafter. The
healing process after (chemo) radiotherapy takes more time
than after surgery.14
Besides the healing process, tumor localization might
influence MMO as well, although the evidence is con-
flicting. The greatest reduction in MMO is most likely
when the tumor is located near risk structures. Risk
structures involve the temporomandibular joint and the
masticatory muscles. A decrease in MMO and an
increase in perceived difficulties with opening the mouth
were found when the tumor was located in proximity of
these risk structures, such as the oral cavity, oropharynx
and nasopharynx, nasal cavity, and maxillary sinus. A
former systematic review on risk factors for trismus
included only one study (the Goldstein et al51) that found
that the MMO was reduced by 18% (SD 17%) when the
temporomandibular joint and/or the pterygoid muscles
were affected.9 A later review concluded that the mastica-
tory related structures generally affect MMO, but the
masseter muscle had the strongest influence.79 More
recently, the ipsilateral medial pterygoid muscle19,80 and
the masseter muscle49,80 were identified as the structures
most likely to result in a decrease in MMO.
A larger target volume, and also a stage IV tumor,
resulted in a large reduction of MMO.15 Both findings are
in contrast with other studies.14,16,54,57,65 Presumably, a
significant effect was found for such a large tumor,
because more risk structures were involved and more
extensive cancer treatment was necessary.
There is limited to moderate evidence that baseline
mouth opening affect MMO.15 A smaller baseline mouth
opening results in a larger decrease in MMO. This large










(+, −, or ±) Level of evidence
Increased score on perceived difficulties opening the mouth
Shorter time after treatment [76] 117 117 + Limited/moderate
Treatment modalities [74;76] 111;117 228 − Conflicting
Multiple treatment modalities





radiotherapy >6 months b
[35;71] 241;60 301 ±
Higher social economic
status
[46] 161 161 + Limited
No addition of
electrofrequency
[72] 83 83 + Limited
Localization [65] 80 80 − Limited
T stage [65] 80 80 − Limited
Note: [number], reference of study, univariate analysis; [number], reference of study, multivariate analysis; +, significant association found
between factor and outcome measure; −, no significant association found between factor and outcome measure; ±, partial association found
between elements within a factor and outcome measure.
aKarnofsky Performance Scale: an index used to classify functional impairment, using a scale of 0-100.
bSignificant associations found between factor and outcome measure on the basis of a particular categorization. This particular categorization
is written in italics.
cThis study analyzed the effects of “radiation field in the area of the oral cavity and oropharynx” on maximal mouth opening, and is therefore
included as part of the potential prognostic factor: “localization.”
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greater. As an elaboration of this found effect, a baseline
mouth opening of 46 mm or less was determined, as a
cut-off point for developing trismus.80
The described effects of sex and age on MMO are con-
flicting. One study found that males tend to have a larger
decrease over time than females.14 Another study found
that the decrease was the same in males and females over
time.16 Yet another study found that females had a higher
risk of a decrease in mouth opening than males.15 Regard-
ing age, one study found that the mouth opening of youn-
ger patients decreased more over time than of older
patients.14 However, another study found that older
patients had a higher risk of a decrease in mouth opening
than younger patients.15 The effects of sex and age may
have been confounded by other factors not reported or
analyzed in those studies. For instance, the genotype of
the patients might have influenced the effect.56 Patients
with the homozygous TT −509 genotype experienced a
greater reduction in MMO than patients with the homozy-
gous CC or heterozygous CT −509 genotype. However, the
evidence for the influence of the −509 genotype is limited.
4.4 | Objective and subjective measures
over time
Diverse patterns were seen over time regarding perceived
difficulties with opening the mouth. Patients' perceptions
FIGURE 2 A, Longitudinal evaluation of percentage of patients with trismus. * indicates that study reported trismus as a secondary
outcome. Broken lines display studies that had overlapping data with other studies. The studies that contained the largest sample size are
displayed as straight lines. B, Longitudinal evaluation of maximal mouth opening. Broken line displays studies that had overlapping data
with other studies. The studies that contained the largest sample size are displayed as straight lines. C, Longitudinal evaluation of patient's
quality of life score-domain: difficulties opening the mouth. * indicates that study reported patient's score of perceived difficulties opening
the mouth as a secondary outcome. Broken lines display studies that had overlapping data with other studies. The studies that contained the
largest sample size are displayed as straight lines
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of difficulties with opening the mouth might be influenced
by different factors over time, such as pain, dry mouth,
overall emotional functioning, or treatment modalities.81,82
4.5 | Strength and limitations
The strength of this study is that we had no restriction
concerning publication year or publication language. Four
databases were searched in order to include as many stud-
ies as possible. Due to the different aims of the studies and
subsequently the different designs of the studies, it was
challenging to structure and interpret the data. Due to
clinical and methodological heterogeneity, no meta-analy-
sis was conducted. Instead, we performed a best evidence
synthesis. Due to this synthesis, we were still able to gain
insight into which prognostic factors should be taken into
account from the 53 included studies. The results of this
systematic review should be viewed cautiously because of
high risk of bias in the source studies.
We used the QUIPS tool to assess bias but it was not
really suitable for those studies whose primary aim was
not to analyze trismus prognostic factors, making it diffi-
cult to assess the studies. Hence, the overall kappa score
was low.
4.6 | Future research
Large sample size studies are recommended with multi-
ple structured measurement moments to analyze prog-
nostic factors. The effects of factors related to healing
tendency and pain intensity on trismus, decrease in
MMO, and perceived difficulties with opening the mouth
should be studied further.
5 | CONCLUSION
A restricted mouth opening is most likely when the
patient with head and neck cancer has a large tumor
located in close proximity to the mastication muscles or
temporomandibular joint that requires extensive cancer
treatment. A restricted mouth opening will most likely
occur in the first 6 months after cancer treatment. More
research is needed on the effect of factors related to
healing tendency and pain intensity on a restricted
mouth opening.
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